ArticlemedRxiv : the preprint server for health sciences2025
Sleep Temporal Entropy as a Novel Digital Biomarker of Sleep Fragmentation for Cardiometabolic and Mortality Risk.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
This study introduces Sleep Temporal Entropy (STE), a novel entropy-based digital sleep biomarker derived from Shannon entropy theory, to quantify sleep fragmentation and explore its associations with cardiometabolic disorders and mortality. Unlike traditional metrics (e.g., Sleep Efficiency, Wake After Sleep Onset), STE captures the complexity of transitions across both sleep-wake and sleep-stage boundaries, providing a multidimensional analysis of sleep architecture. Based on two distinct cohorts-a clinic-based cross-sectional population and a community-based longitudinal population-the biomarker demonstrated consistent performance across multiple outcomes. In the Shanghai Sleep Health Study Cohort (SSHSC, n=3,219), STE consistently outperformed established metrics in predicting hypertension, diabetes, and hyperlipidemia. In the Sleep Heart Health Study (SHHS, n=4,862), STE demonstrated robust U-shaped associations with both all-cause and cardiovascular mortality, with REM STE emerging as the most significant and independent predictor. Key innovations of this study include the application of STE in cross-cohort and multi-outcome validations, direct performance comparisons with existing metrics, and the identification of nonlinear health impacts. These findings contribute to advancements in sleep biomarker research, suggesting that STE could provide valuable insights for clinical and research applications in sleep health and cardiometabolic risk assessment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.